TerminatedNCT00535262
A Pilot Study Assessing EmSam in Depression in bipolarity
Researchers are studying EmSam, tracking side effects to assess safety and tolerability in people with bipolarity during a depressive episode.
Medication studyAges 18–65United States
Understand this study
What is this study about?
Researchers are studying EmSam, tracking side effects to assess safety and tolerability in people with bipolarity during a depressive episode.
Who could participate?
This study is for people with bipolarity. Listed age limits: 18 years to 65 years. Other eligibility criteria apply.
- Listed locations
- New YorkSee all locations and recruitment
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateMarch 2007
- Recruitment status
- Terminated
- Enrollment listed in the registry
- 3
- Sponsor
- New York State Psychiatric Institute
- Sponsor type
- Research institute
- Study type
- Drug
- Intervention type
- Drug
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
- Locations
- United States
- Age range
- From 18 Years to 65 Years
- Official registry ID
- NCT00535262
- Official title
Show the full official title
A Pilot Study Assessing Efficacy, Safety, and Tolerability of EmSam in Bipolar Depression
Recruitment & locations
TerminatedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
New York
Interested in joining this study?
Questions about this study
What is this study about?
Researchers are studying EmSam, tracking side effects to assess safety and tolerability in people with bipolarity during a depressive episode.
Who is behind this study?
The study sponsor is New York State Psychiatric Institute, a research institute.
Does this study involve medication?
Yes. The study involves medication, including EmSam.
Who can participate?
This study is for people with bipolarity. Listed age limits: 18 years to 65 years. Other eligibility criteria apply.
Is this study still recruiting?
The registry lists this study as terminated.
Want to explore more studies?
Explore studiesRelated studies
16-week Comparative Effectiveness Trial of Lamotrigine vs. Fluoxetine for Depression in bipolarity
A Clinical Study of an Investigational Drug for the Treatment of Major Depressive Episode Associated With Bipolarity type I.